<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="306509" id="root" date="1997-01-14" xml:lang="en">
<title>USA: Neoprobe technology approved in S. Korea.</title>
<headline>Neoprobe technology approved in S. Korea.</headline>
<dateline>DUBLIN, Ohio 1997-01-13</dateline>
<text>
<p>Neoprobe Corp on Monday said its RIGScan technology for use in cancer surgery received marketing approval in South Korea.</p>
<p>Neoprobe said it expected to begin shipment of its RIGScan CR49 in the first quarter. The technology is expected to be used initially  for surgery for metastatic colorectal cancer.</p>
<p>RIGS technology involves injecting patients before surgery with a low-energy radioactive drug that targets cancer cells. Surgeons then use a handheld gamma-detecting probe to locate tissue containing significant amounts of the targeting agent.  </p>
<p>Neoprobe said it may eventually be used for other cancers.</p>
<p>It has been used in research on stomach and pancreatic cancers, Neoprobe said.</p>
<p>The company is also seeking regulatory approvals in the U.S., Europe and elsewhere.</p>
<p>&quot;This is an exciting first step toward the worldwide commercialization of our RIGS surgical detection products,&quot; Neoprobe President David Bupp said in a statement.</p>
<p>Neoprobe's Korean marketing and distribution partner, Damon Pharm Ltd, has begun promoting RIGScan CR49 in Korea and also has marketing and distribution rights in Malaysia, Singapore, Taiwan and Thailand, Neoprobe said.</p>
<p>((Cleveland Newsdesk, Susan Zimmerman 216-579-0077))</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="SKOREA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-14"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-14"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I37200">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-14"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C13">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-14"/>
  </code>
  <code code="C22">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-14"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-14"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-01-13"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-01-14"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="DUBLIN, Ohio"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
